Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1300 of 3173 entries
View as:

A Study To Investigate The Taste Of Crizotinib Liquid In Trained Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01125904 Org: User:
Start: 06/30/10 End: 06/30/10 Due: 06/30/11

Safety and Efficacy of Pf-06650833 In Subjects With Rheumatoid Arthritis, With An Inadequate Response To Methotrexate

Phase: N/A Priority: Normal
NCT ID: NCT02996500 Org: User:
Start: 11/10/16 End: 08/15/18 Due: 08/15/19

Diflucan Bioequivalence Study For Transferring The Manufacture

Phase: N/A Priority: Normal
NCT ID: NCT03821480 Org: User:
Start: 01/28/19 End: 03/06/19 Due: 03/06/20

Efficacy And Safety Of Bococizumab For Lipid Lowering In Asian Hypercholesterolemia Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02947334 Org: User:
Start: 10/31/16 End: 05/03/19 Due: 05/03/20

A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo for Smoking Cessation

Phase: N/A Priority: Normal
NCT ID: NCT00141167 Org: User:
Start: 02/28/05 End: 01/31/06 Due: 01/31/07

A Pharmacokinetic And QT Study Of CP-751,871 In Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00926263 Org: User:
Start: 07/31/09 End: 05/31/10 Due: 05/31/11

Observational Study Investigating Clinical & Anthropometric Characteristics of Children With Achondroplasia.

Phase: N/A Priority: Normal
NCT ID: NCT03794609 Org: User:
Start: 06/15/18 End: 01/13/23 Due: 01/13/24

A Study to Evaluate Safety, Toleration and Time Course of Plasma Concentration of Multiple Oral Doses of PF-06372865 in Healthy Subjects of Two AgeGroups, Aged 18-55 Years (Group 1) and Aged 56-75 Years (Group 2)

Phase: N/A Priority: Normal
NCT ID: NCT02070289 Org: User:
Start: 03/31/14 End: 07/31/14 Due: 07/31/15

Drug Interaction Study Between Raltegravir And UK-453,061

Phase: N/A Priority: Normal
NCT ID: NCT00784420 Org: User:
Start: 09/30/08 End: 11/30/08 Due: 11/30/09

An Open-Label Safety Study Of DIC075V (Intravenous Diclofenac Sodium) In Patients With Acute Post-Operative Pain

Phase: N/A Priority: Normal
NCT ID: NCT00726388 Org: User:
Start: 09/15/08 End: 05/08/09 Due: 05/08/10

Crizotinib Plus Pembrolizumab In Alk-Positive Advanced Non Small Cell Lung Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT02511184 Org: User:
Start: 10/31/15 End: 12/31/17 Due: 12/31/18

PF-06671008 Dose Escalation Study in Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02659631 Org: User:
Start: 04/28/16 End: 03/29/19 Due: 03/29/20

A Phase I Study to Assess the Safety, Tolerability and PK of Ceftazidime-Avibactam in Healthy Chinese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01920399 Org: User:
Start: 10/31/13 End: 11/30/13 Due: 11/30/14

A Phase 1 Multiple-Dose Escalation and Single Dose (Tablet) Study of PF-04171327 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00812825 Org: User:
Start: 01/31/09 End: 07/31/09 Due: 07/31/10

Test Re-Test Reliability of [11C]PF-06809247 as a Novel PET Tacer

Phase: N/A Priority: Normal
NCT ID: NCT03100136 Org: User:
Start: 11/16/16 End: 03/10/17 Due: 03/10/18

A Study To Examine Safety, Pharmacokinetics, And Pharmacodynamic Of Pf 06412562 In Subjects With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT02418819 Org: User:
Start: 04/30/15 End: 10/31/16 Due: 10/31/17

A Healthy Volunteer Study To Assess Relative Bioavailability Of Powder-In-Capsule And A Tablet Formulation And The Effect Of Food On The Pharmacokinetics Of The Tablet Formulation

Phase: N/A Priority: Normal
NCT ID: NCT01821079 Org: User:
Start: 03/31/13 End: 04/30/13 Due: 04/30/14

Study Evaluating the Mechanism of Action of PF-04965842 Monotherapy for Moderate-to-severe Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT03915496 Org: User:
Start: 06/18/20 End: 11/16/21 Due: 11/16/22

A Study Of Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley)

Phase: N/A Priority: Normal
NCT ID: NCT02554812 Org: User:
Start: 11/09/15 End: 03/23/23 Due: 03/23/24

Retrospective Chart Review Study to Assess Characteristics, Treatment Outcomes and Resource Use of Adults Hospitalized for CAP and CSSTi Treated With Zinforo in Multiple Countries

Phase: N/A Priority: Normal
NCT ID: NCT04198571 Org: User:
Start: 05/17/20 End: 08/30/21 Due: 08/30/22

Sunitinib Malate Schedule 4/2 vs. Sunitinib Malate Continuous Dosing As First-Line Therapy For Metastatic Renal Cell Cancer (RCC)

Phase: N/A Priority: Normal
NCT ID: NCT00267748 Org: User:
Start: 12/31/05 End: 06/30/10 Due: 06/30/11

Study Providing Monotherapy (Sitaxsentan) And Combination Therapy (Sitaxsentan+Sildenafil) To Subjects With Pulmonary Arterial Hypertension (PAH) To Assess Long-Term Safety

Phase: N/A Priority: Normal
NCT ID: NCT00796510 Org: User:
Start: 07/31/10 End: 01/31/11 Due: 01/31/12

A Study To Assess Esreboxetine's Effect On Concentration, Memory, Decision Making And Problem Solving In Patients With Fibromyalgia.

Phase: N/A Priority: Normal
NCT ID: NCT00752505 Org: User:
Start: 08/31/08 End: 06/30/09 Due: 06/30/10

Non-Interventional Open Label Prospective Observational Comparative Study On Evaluation Of Compliance Of The Empiric Treatment With Azithromycin SR Versus Amoxiclav 1000 Mg In Adult Patients With Mild To Moderate Community Acquired Pneumonia

Phase: N/A Priority: Normal
NCT ID: NCT01032694 Org: User:
Start: 04/30/10 End: 12/31/10 Due: 12/31/11

A Study of ARRY-382 in Combination With Pembrolizumab for the Treatment of Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02880371 Org: User:
Start: 09/01/16 End: 10/24/19 Due: 10/24/20